Teligent Inc. (NASDAQ:TLGT) will be posting its quarterly earnings results on Thursday, October 20th.

Teligent (NASDAQ:TLGT) last released its earnings results on Thursday, July 28th. The company reported $0.02 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.04. Teligent had a negative return on equity of 1.49% and a negative net margin of 22.81%. The company had revenue of $17.14 million for the quarter, compared to analysts’ expectations of $16.03 million. During the same quarter in the previous year, the business posted ($0.05) EPS. The business’s revenue for the quarter was up 92.8% on a year-over-year basis. On average, analysts expect Teligent to post $0.01 EPS for the current fiscal year and $0.21 EPS for the next fiscal year.

Teligent Inc. (NASDAQ:TLGT) opened at 7.08 on Tuesday. The stock’s market cap is $375.91 million. Teligent Inc. has a 1-year low of $4.46 and a 1-year high of $9.18. The firm’s 50-day moving average price is $7.63 and its 200 day moving average price is $6.93.

A number of institutional investors have recently added to or reduced their stakes in TLGT. Elk Creek Partners LLC raised its position in Teligent by 12.8% in the second quarter. Elk Creek Partners LLC now owns 2,589,771 shares of the company’s stock valued at $18,491,000 after buying an additional 293,063 shares during the last quarter. Guggenheim Capital LLC bought a new position in Teligent during the second quarter valued at $1,319,000. Menta Capital LLC raised its position in Teligent by 65.5% in the second quarter. Menta Capital LLC now owns 112,085 shares of the company’s stock valued at $800,000 after buying an additional 44,380 shares during the last quarter. Janus Capital Management LLC raised its position in Teligent by 1.7% in the second quarter. Janus Capital Management LLC now owns 4,857,372 shares of the company’s stock valued at $34,682,000 after buying an additional 78,879 shares during the last quarter. Finally, Allianz Asset Management AG raised its position in Teligent by 20.6% in the second quarter. Allianz Asset Management AG now owns 585,465 shares of the company’s stock valued at $4,180,000 after buying an additional 100,012 shares during the last quarter. 69.64% of the stock is currently owned by hedge funds and other institutional investors.

TLGT has been the topic of several research analyst reports. Raymond James Financial Inc. initiated coverage on Teligent in a report on Wednesday, June 22nd. They set a “strong-buy” rating and a $11.00 target price on the stock. Zacks Investment Research raised Teligent from a “hold” rating to a “buy” rating and set a $8.75 price target on the stock in a research note on Wednesday, October 12th. TheStreet raised Teligent from a “sell” rating to a “hold” rating in a research note on Thursday, June 23rd. Finally, JMP Securities initiated coverage on Teligent in a research note on Wednesday, June 29th. They set a “hold” rating on the stock. Four analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company. Teligent currently has an average rating of “Buy” and a consensus price target of $9.25.

About Teligent

Teligent, Inc, formerly IGI Laboratories, Inc, is a specialty generic pharmaceutical company. The Company markets and sells generic injectable pharmaceutical products under its own label in the United States and Canada. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries.

5 Day Chart for NASDAQ:TLGT

Receive News & Stock Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related stocks with our FREE daily email newsletter.